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12-O-tetradecanoylphorbol 13-acetate (TPA) induces the diﬀerentiation of human myeloid ML-1 cells to macrophages. In
the current study, the expression, responsiveness, and regulation of toll-like receptors (TLRs) in TPA-induced ML-1-derived
macrophages were investigated. We have found that TPA-induced diﬀerentiation of ML-1 cells was accompanied by the
upregulation of TLR1, TLR2, TLR4, and CD14 expression at both the mRNA and protein levels. Interestingly, TLR1 and
TLR4 protein expression on ML-1 cells could be blocked by pretreatment with U0126, suggesting the role of an Erk1/2-
induced diﬀerentiation signal in this process. In addition, the expression of IRAK-2, a key member of the TLR/IRAK-2/NF-κB-
dependent signaling cascade was also induced in response to TPA. Accordingly, we demonstrated an increased cellular release of
inﬂammatory cytokines (TNF-α and various interleukins) upon stimulation with LPS and LTA ligands for TLR4 and TLR2,
respectively. Furthermore, using luminol-dependent chemiluminescence, addition of LPS and LTA induces a sustained DPI-
inhibitable generation of reactive oxygen species (ROS) by the diﬀerentiated ML-1 cells. Together, these data suggest that the
increase in the responsiveness of TPA-treated ML-1 cells to LPS and LTA occurs in response to the upregulation of their respective
receptors as well as an induction of the IRAK-2 gene expression.
1.Introduction
Humans are confronted with a number of microorganisms,
viruses, and parasites that require continued surveillance
and defense against [1, 2]. polymorphonuclear leukocytes
(PMNs), monocytes, and tissue macrophages are important
cells in the innate immune response to microorganisms
and parasites [1, 3]. All derived from the same myeloid
progenitor cell in the bone marrow [2]. Blood monocytes
are an intermediate stage of development which then further
diﬀerentiates in tissues to various macrophage popula-
tions. Tissue macrophages, as well as, other cells of the
innate immune system, are critical for these surveillance
and defense activities [3]. Upon stimulation by microbial
particles or other endogenous factors such as cytokines,
macrophages can de novo synthesize and release a large
variety of cytokines (IL-1, IL-6, IL-8, IL-10, IL-12, TNFα,
IFNα,I F N γ, MCP-l, MCP-3, MIF, M-CSF, G-CSF, GM-
CSF, MIP-l, MIP-2, LIF, OSM, and TGF-β). Some cytokines
can stimulate the production of cytokines by macrophages
(IL-3, GM-CSF, IFNγ), while others can suppress it (IL-4,
IL-10, IL-13, TGFβ). In addition, in many organs, tissue
macrophagesserveasimportant regulatorycells[4],through
their synthesis and secretion of a spectrum of cytokines and
growth factors [5–7].
Toll-like receptors (TLRs)of mammalianinnate immune
defensesystemsplayacrucialroleintheinitiationofadaptive
immune responses to bacteria invasion [8–11]. A critical
feature of macrophages required for speciﬁc recognition
and response includes the expression of optimum levels of2 ISRN Oncology
diﬀerent TLRs [8–11]. Upon the interaction with speciﬁc
pathogen-associatedmolecularpatterns(PAMPs),TLRstrig-
ger the signal transduction cascades that lead to cellular
responses including the engulfment of invasive microbes,
induction of inﬂammatory cytokines, and generation of
ROS to kill the invasive pathogens. Several mammalian
TLRs genes have been identiﬁed, and at least ten human
TLRs have been cloned. TLR1, predominantly distributed
in monocytes/macrophages and PMNs, is implicated with
TRL2 in the recognition of the native conﬁguration of
mycobacterial lipoprotein and several other lipopeptides
[10, 12]. TLR2 recognizes Gram-positive bacteria-derived
Lipoteichoic acid (LTA). TLR4 and CD14, on the other
hand, are required for the recognition of the Gram-
negative bacteria-derived lipopolysaccharide (LPS). During
sepsis, the binding of LPS to extracellular domain of TLR4
receptors on phagocytic cells, macrophages, and neutrophils
elicits activation of the TLR4/IRAK-2/NF-κBc o m p l e xt o
signal production and release of proinﬂammatory mediators
(cytokines) phagocytic cells [13]. Although TLRs play an
important role in the adequate response of immune cells,
the deregulation of their expression and function causes
defective immune responses [14–16] and the occurrence of
chronic diseases [17–19].
To understand the molecular mechanisms underlying
macrophage diﬀerentiation, investigators have turned to
human myeloid cell lines such as HL-60, U937, THP-1, and
ML-1 [20–23]. In vitro, these myeloid cell lines continuously
proliferate in suspension culture and can be induced to dif-
ferentiate into macrophages by 12-O-tetradecanoylphorbol-
13-acetate (TPA) or 1,25-dihydroxyvitamin D3 [24]. These
cell lines have been widely used as cell models for studying
the molecular and cellular aspects of myeloid diﬀerentiation.
ML-1 cells were originally isolated from a patient with
acute myeloblastic leukemia [25, 26]. These cells read-
ily diﬀerentiate into macrophages in response to a low
concentration of TPA (0.3ng/mL or 0.5nM) [25, 26]. In
this process, the diﬀerentiation signal induced by TPA is
mediated via a redox-regulated extracellular receptor kinase
(Erk1/2) [27]. Diﬀerentiated ML-1 cells demonstrate a
number of biochemical and functional endpoint indicators
ofmacrophagediﬀerentiationincluding:nonspeciﬁcesterase
(NSE) phagocytosis, plasma membrane NADPH oxidase
and accompanying superoxide generation, and cell surface
markers [28–31]. In the present study, we have characterized
thetemporalupregulationofTLR1,TLR2,TLR4,andIRAK2
expression during the diﬀerentiation of ML-1 cells leading to
increasedresponsivenesstoLPSandLTA.Ourdataalsoshow
that the increased expression of TLR1 and TLR4 induced
by TPA is at least in part mediated through activation of
ERKs.
2.MaterialandMethods
2.1. Antibodies and Reagents. Lipoteichoic acid (LTA) (major
constituent of the Gram-positive bacteria cell wall) and
lipopolysaccharide (LPS) (Escherichia coli) were purchased
from Sigma-Aldrich. The human cytokines IL-1 alpha, IL-1
beta, IL-6, IL-8, IL-10, IL-12(p40), GMCSF, IFN-gamma,
TNF-α and IP-10 cytokine multiplex immunoassay reagents
were obtained from Upstate Biotechnology, Lake Placid,
NY, USA. The Alexa Fluor 488-labeled mouse anti-human
Abs against TLR1, TLR4, CD14, and Alexa Fluor 488-
labeled isotype controls (mouse IgG1) were obtained from
Molecular Probes.
2.2. Cell Culture. Human myeloid leukemia ML-1 cells,
originally isolated from a patient with acute myeloblastic
leukemia, were kindly provided by Dr. Ruth Craig, Dart-
mouth School of Medicine, NH. All cell culture media
and supplements were obtained from Invitrogen (Carlsband,
CA). Cells were cultured in RPMI 1640 Medium supple-
mented with 10% heat-inactivated fetal bovine serum, 2mM
L-glutamine, antibiotics (50 U/mL penicillin and 50μg/mL
streptomycin), and maintained at 37◦C in a humidiﬁed
5% CO2 atmosphere as previously described [25, 26, 32].
Experiments were routinely carried out using cells in the
log phase of growth. The diﬀerentiation of ML-1 cells to
macrophages entails a 6-day protocol: three days exposure
to TPA (5nM) and followed by three days of culture
in the absence of TPA. Both the concentration of TPA
used and the time of its presence are critical for opti-
mal macrophage diﬀerentiation, particularly mitochondrial
maturation.
TPA (Sigma Chemical Co., St. Louis, MO) was dissolved
in DMSO to obtain a 100μM stock solution and further
diluted before use. For all experiments, cells were cultured
at an initial density of 5 × 105 cells/mL. For negative
controls, the cells were incubated in the absence of TPA, in
medium containing an equivalent 1% (v/v) DMSO. Viability
was determined by hemocytometer counts of trypan blue-
impermeable cells.
2.3. Microarray Analysis. ML-1 cells were grown at density
of 105 cells/mL in a 150mL dish and treated with vehicle
(DMSO) or 5nM TPA (n = 3). Total RNA was extracted
using Trizol reagent and puriﬁed with the Qiagen RNAeasy
minikit. The puriﬁed RNA was subjected to Aﬀymetrix
oligonucleotide microarray analysis using Human Genome
U133 2.0 Plus Array Chip. Six replicates, including three
controls and three TPA treated ML-1 cells samples, were
examined.
2.4.DeterminationofTLR-1,TLR-4,andCD14byFACSAnal-
ysis. The levels of TLR1, TLR4, and CD14 were determined
usingFACS-Scananalysis.Cells(1×106)resuspendedinPBS
containing 0.1% sodium azide and 5% FBS were incubated
on ice for 30min and then incubated with (Alexa-ﬂuor 488)
conjugated anti-TLR1, TLR4, or CD14 antibodies for 1 hour.
The cells were washed twice, ﬁxed in 2% formaldehyde in
PBS, and analyzed by FACS-Scan analysis. Negative con-
trols were stained with isotype-matched (Alexa-Fluor 488)-
conjugated IgG and compensation was adjusted using the
single-stained cell samples. The ﬂuorescence intensities were
determined using Cellquest software (Becton Dickinson,
Bedford, MA).ISRN Oncology 3
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Figure 1: Human myeloid ML-1 cell treatment with TPA is associated with the induction macrophages speciﬁc protein CD14 expression
at both mRNA and protein levels. ML-1 cells were incubated in the presence or in the absence of 5nM TPA for the indicated times. (a)
CD14 mRNA levels were determined by examination of microarray analysis data (see Section 2). (b) The levels of CD14 protein expression
on TPA-treated ML-1 cells were determined by FACS-Scan analysis using Alexa-Fluor 488 labeled anti-human CD14 antibodies. Negative
controls were stained with isotype-matched- (Alexa-Fluor 488) conjugated IgG, and compensation was adjusted using the single-stained cell
samples. The ﬂuorescence intensities were determined using Cellquest software (Becton Dickinson, Bedford, MA). Data were analyzed by
ModFILT statistical software. The ﬁgure depicts representative results from one of three replicate experiments.
2.5. Measurement of Inﬂammatory Mediators. Selected panel
of inﬂammatory mediators (IL-1 alpha, IL-1 beta, IL-6,
IL-8, IL-10, IL-12(p40), GMCSF, IFN-gamma, TNF-a, and
IP-10) in cell culture medium were analyzed following
stimulation of ML-1 cells or diﬀerentiated ML-1 cells (dML-
1) with LPS or LTA for 16 hours, using cytokine multiplex
immunoassay reagents (Upstate Biotechnology, Lake Placid,
NewYork,UnitedStates)analyzedbyLuminex100(Luminex
Corporation, Austin, Texas, United States).
2.6. Measurement of ROS Generation by Luminol-Derived
Chemiluminescence. The generation of cellular ROS, in
particularextracellular H2O2, was assessed using horserad-
ish peroxidase-dependent luminol-derived chemilumines-
cence(CL) as previously described [33]. One million cells
were incubated with luminol (10μM) and horseradish
peroxidase (10μg/mL) in complete PBS, 500μL (PBS with
0.5mM MgCl2,0.7mM CaCl2, 0.1% glucose). Cellular CL
was measured continuously in a Berthold LB9505 lumi-
nometer (Pforzheim, Germany) for 1.5 hours.
3. Results
3.1. TPA Induces TLR1, TLR2, TLR4, and IRAK-2 Gene
Expression in ML-1 Cells. In our previous studies, we have
demonstrated that human myeloid ML-1 cells diﬀerentiate
to macrophages upon stimulation with the phorbol ester
TPA [34]. To further conﬁrm that TPA-treated ML-1 cells
exhibit macrophage characteristics, CD14 gene expression,
a key macrophage marker, was determined at the mRNA
and protein level. Examination of the microarray analysis
(Figure 1(a)), and ﬂow cytometry analysis (Figure 1(b))
revealed a strong induction of CD14 gene expression upon
stimulation with TPA and in a time-dependent fashion.
Toll-like receptors (TLRs) of mammalian innate immune
defense systems play a crucial role in the initiation of
adaptive immune responses to bacteria invasion [8–11].
Accordingly, we assessed the temporal expression of diﬀerent
TLR gene products in response to TPA-induced macrophage
diﬀerentiation of Ml-1 cells. Analysis of microarray data
revealed signiﬁcant increases in the mRNA levels of TLR1,
TLR2, TLR4, and TLR8 expression also that of IRAK-2
in ML1 cells compared to control (DMSO-treated cells)
(Figure 2). Interestingly, only the gene expression of the TLR
members indicated above were changed in response to TPA.
AsshowninFigure 2,themRNAforeachoftheTLRsshowed
diﬀerent expression patterns, with TLR4 showing maximum
mRNA as early as 6 hours of TPA addition, after which it
decreased. Interestingly, IRAK-2 mRNA exhibited the same
temporal pattern as TLR4 (Figure 2(b)). The mRNA for
TLR1 appeared at 3 days and remained constant. On the
other hand, the mRNA for TLR2 and TLR8 was apparent at
6d a y so fd i ﬀerentiation.
Flow cytometry analysis conﬁrmed enhanced TLR1
and TLR4 protein expression by ML-1cells (Figure 3(a)).
Immunocytochemistry data revealed a basal level of expres-
sion of TLR4 but not TLR1 in the undiﬀerentiated ML-1
cells (Figure 3(b)), which increased with macrophage diﬀer-
entiation. In our previous studies [23, 27, 35], we reported
that the mitogen-activated protein kinase (MAPK) cascade
plays a crucial role in the initiation of the macrophage
diﬀerentiation signal induced by TPA. Using U0126, a MEK
inhibitor, we examined whether MAPK-derived diﬀerentia-
tion signal was required for TLR-1 and TLR-4 expression-
induced by TPA in ML-1 cells. Pretreatment with 10μM
U0126 eﬀectively blocked both TLR1 and TLR4 protein
expression induced by TPA in ML-1 cells (Figure 4). Since
ML-1 cells already expressed a basal level of TLR4 protein,4 ISRN Oncology
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Figure 2: Expression of TLR mRNA expression in ML-1 cells. Six million cells were incubated in the presence TPA of (5nM) or vehicle
(DMSO) for indicated times. Total RNAs were extracted from cell samples using Trizol reagents, puriﬁed with the Qiagen RNAeasy mini
kit and analyzed by microarray analysis using human Genome U133 2.0 PlusArray Chip. Six replicates including three controls (DMSO-
treated) and three TPA-treated ML-1 cells samples were examined. The levels of (a) TLR1, TLR2, TLR4 and TLR8 and (b) IRAK-2 mRNAs
were determined by examination of the microarray analysis data.ISRN Oncology 5
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Figure 3: TPA induces upregulation of TLR1 and TLR4 proteins expression in human myeloid ML-1 cells. Three millions cells were
incubated with 5nM TPA for various times (24hrs, 3 days, and 6 days). (a) Cells were then harvested, washed with PBS, ﬁxed with
formaldehyde (2%), permeabilized with ice methanol, and stained using (Alexa-Fluor-488-) labeled anti-human TLR1 or TLR4 antibodies.
The levels of TLR1 or TLR4 protein expression in TPA-treated ML-1 cells were determined by FACS-Scan analysis. Negative controls were
stained with isotype-matched- (Alexa-Fluor 488) conjugated IgG and compensation was adjusted using the single-stained cell samples.
The ﬂuorescence intensities were determined using Cellquest software (Becton Dickinson, Bedford, MA). Data were analyzed by ModFILT
statistical software. The ﬁgure depicts representative results from one of three replicate experiments. (b) After transfer onto microscope
slides, cells were washed with PBS, ﬁxed with formaldehyde (2%), permeabilizes with PBS containing 0.25% Triton X-100, and stained
using (Alexa-Fluor 488 labeled anti-human TLR1 or TLR4 antibodies). The levels of TLR1 or TLR4 protein expression were examined using
ﬂuorescent microscope.
the observed increase in LPS and LTA response may be due
in part to the upregulation of IRAK-2 gene expression in
response to TPA. Together, these observations suggested that
TLR1, TLR2 TLR4, and CD14 and IRAK-2 gene expression
is induced in ML-1 cells upon stimulation with TPA. This
observation is supported by a previous report that TPA
induces TLR2 expression in U937 cells [36].
3.2. Diﬀerentiated Human Myeloid ML-1 Cells Exhibit Pro-
duction of Inﬂammatory Cytokines in Response to LPS and6 ISRN Oncology
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Figure 4: To determine the role of mitogen-activated protein kinase signal in TPA-induced TLR1 and TLR4 expression in ML-1 cells.
Three millions cells were pretreated with 10μM U0126 for 10 minutes followed by incubation with 5nM TPA for 24 hours. Cells were then
harvested, washed, ﬁxed, permeabilizes, and stained using (Alexa-Fluor-488-) labeled anti-human TLR1 or TLR4 antibodies. The levels of
TLR1 or TLR4 protein expression in TPA-treated ML-1 cells were determined by FACS-Scan analysis. Negative controls were stained with
isotype-matched- (Alexa-Fluor 488) conjugated IgG and compensation was adjusted using the single-stained cell samples. The ﬂuorescence
intensities were determined using Cellquest software (Becton Dickinson, Bedford, MA). Data were analyzed by ModFILT statistical software.
The ﬁgure depicts representative results from one of three replicate experiments.
LTA. To determine whether TPA-diﬀerentiated ML-1 cells
exhibit macrophage-like responses following stimulation
with bacterial particles LPS and LTA, cytokine multiplex
immunoassay was used to assess the levels of selected
cytokine production and release. Incubation with LTA
(10μg/mL) and LPS (100ng/mL) resulted in robust pro-
duction of various cytokines by the diﬀerentiated ML-1cells
(Figure 5). However, there were several diﬀerences noted
between LPS and LTA. For example, LPS either induced IL-
1 alpha and beta, IL-6, TNF alpha and IP-10, or to a much
greaterextentthanLTA.ThepresenceofIL-10,IL-12p40,and
interferon gamma was similar in response to LPS and LTA.
These observations support our previous ﬁndings that TPA
treatment induces ML-1 cell diﬀerentiation to functional
macrophages [20].
3.3. LPS and LTA Induces Sustained Generation of ROS
in Diﬀerentiated ML-1 Cells. To determine whether TPA-
diﬀerentiated ML-1 cells exhibit a change in ROS levels
in response to LPS and LTA, luminol-derived CL was
used. Horseradish peroxidase-dependent luminol-derived
CL indicates the presence of extracellular hydrogen per-
oxide [31]. As shown in Figure 6, ML-1 cells exhibit a
signiﬁcant luminol-derived CL, indicative of the presence
of extracellular hydrogen peroxide. We have previously
determined that in unstimulated macrophages that this
basal ROS is mitochondrial in origin [31]. No luminol-
derived CL is observed with undiﬀerentiated ML-1 cells. The
diﬀerentiated ML-1 cells exhibited a delayed but a more
sustained production of hydrogen peroxide in the presence
of LPS or LTA. Addition of DPI (10μM), a potent inhibitor
of NAD(P)H-dependent enzymes, rapidly suppressed the
luminol-derived CL suggesting a role of NADPH oxidase
and/ormitochondriacomplexIintheobservedROSproduc-
tion by ML-1 cells (Figure 6). The basal unstimulated ROS
production by diﬀerentiated ML-1 cells was also blocked
by DPI, as previously shown (Figure 6). Interestingly, the
sustained, increased ROS with LPS or LTA treatment was
not apparent until 30–40 minutes after their addition. In this
regard, ROS from NADPH oxidase in alveolar macrophages
isapparentalmostimmediatelyafterTPAadditiontoactivate
PKC [37].
4. Discussion
Macrophages are key members of the innate immune system
and are known to play crucial roles in initiating and
maintaining the immune response [38, 39]. Our immuno-
cytochemistry data show a basal expression of human
myeloid ML-1 cells diﬀerentiate into macrophage-like cells
when incubated with TPA [20]. We have demonstrated
that the TPA-induced diﬀerentiation signal is mediated via
a redox-mediated activation of the extracellular-regulated
kinase (Erk1/2), a family member of mitogen-activated
protein kinases, MAPKs, to signal cell growth arrest and
cell attachment during the initiation of the diﬀerentiation
process [23, 27]. In the present study, we investigated the
mechanism by which TPA treatment may lead to increase
in ML-1 cell response to stimulation by bacterial particle
LPS and LTA. We have shown that TPA treatments result
in the upregulation of TLR1, TLR2, TLR4, and CD14 in
ML-1 cells, which lead in part to the potentiation of their
responses to LPS and LTA. This observation correlates with a
previous study by Shuto et al. in 2007, which has suggested
the existence of a direct correlation between the levels of
TLR2 proteins expression and the cellular response to TLR2
ligands in diﬀerentiated HL-60 cells [40]. In addition, a
study by Jang et al. in 2005 has also shown an induction of
TLR2 gene expression in response to TPA in U937 cells [36].
Our immunocytochemistry data show a basal expression ofISRN Oncology 7
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Figure 5: Enhanced LPS and LTA responsiveness in ML-1 cells. One millions cells were incubated for 3 days with medium alone or medium
containing 5nM TPA. Cells were washed after 3 days with PBS to remove TPA, followed by incubation with medium alone for additional
three days to complete the diﬀerentiation process. Six days diﬀerentiated cells were gently washed with PBS and incubated in the absence
or in the presence of 100ng/mL LPS or 10ng/mL LTA for 16h. The culture medium was collected, and the levels of selected inﬂammatory
mediators proteins (IL-1 a, IL-1 b, IL-6, IL-8, IL-10, IL-12(p40), GMCSF, IFN-gamma, TNF-a, and IP-10) in cell culture medium were
determined using cytokine multiplex immunoassay reagents (Upstate Biotechnology, Lake Placid, New York, United States) analyzed by
Luminex 100 (Luminex Corporation, Austin, TX, USA). Data are mean −SE of four separate experiments.
TLR4 but not TLR1 in undiﬀerentiated ML-1 cells. However,
upon TPA treatment, both TLR1 and TLR4 expressions were
upregulated not only at the mRNA but also at the protein
level.
An interesting ﬁnding is that interleukin-1 receptor-
associatedkinases(IRAK-2)mRNAweresigniﬁcantlyupreg-
ulated in response to TPA treatment in ML-1 cells. The
induction of IRAK-2 expression in ML-1 cells correlates with
the observed increase responsiveness to TLR2 and TLR4
ligands (LPS and LTA). IRAK-2 has been implicated to
participate in multiple toll-like receptor signaling pathways
that lead to NF-κB activation and inﬂammatory cytokine
production [41, 42]. IRAK-2 loss-of-function mutants or
knock-down of IRAK-2 expression by small interfering
RNA suppresses TLR3, TLR4, and TLR8 signaling to NF-
κB in human cell lines, and importantly, TLR4-mediated
chemokine production in primary human cells [41, 42].
Together, these observations strongly suggest that TPA
treatment not only induces TLR1, TLR2, and TLR4 genes
expression,butalsothatoftheIRAK-2inML-1cells.IRAK-2
participates in multiple toll-like receptor signaling pathways
that lead to NF-κB via activation and inﬂammatory cytokine
production. The regulation of IRAK-2 gene expression
is known to play a role in the control mechanism of
inﬂammatory responses. Many diﬀerent studies have linked
IRAK-2 to a control point for TLR4-mediated signaling [41].8 ISRN Oncology
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Figure 6: LPS and LTA induce sustained generation of reactive
oxygen species (ROS) in TPA- diﬀerentiated ML-1 cells. ML-1
cells were incubated with TPA 5nM for three days followed by
incubation with growth media in absence of TPA for three days.
The diﬀerentiated ML-1 cells were harvested, washed with PBS, and
ROS assessed using Luminol-derived luminescence. Extracellular
hydrogen peroxide produced by 1 million cells was measured in
Berthold luminometer in the presence or absence of 100ng/mL
LPS or 10ng/mL. CL is quantiﬁed as cpm x 106 over the indicated
time period. As indicated on the time curve, 10μMD P Iw a s
injected directly into the reaction mixture. The luminol-dependent
CL of undiﬀerentiated ML-1 cells is at the background level of the
Berthold luminometer. The ﬁgure depicts results from one of three
replicate experiments.
Since ML-1 cells express basal TLR4 level, the upregulation
of IRAK-2 gene expression in response to TPA appears to
be at least in part a determinant factor in the increased
NFκB-mediated cytokines production induced by LPS and
LTA. TLRs expression on macrophages is essential for
recognition and response to bacterial particle [8–11, 43].
As such, impaired expression of TLRs has been associated
with defective innate immune response [14]. For example,
macrophages from TLR1−/− mice and TLR2−/− mice were
shown to be hyporesponsive to Borrelia burgdorferi outer-
surface lipoprotein (OspA) vaccination [16]. Therefore,
defects in the TLR1/2 signaling pathway may account for
human hyporesponsiveness to OspA vaccination. Interest-
ingly, recent studies have proposed that the overexpression
of TLR4 may play roles in the occurrence of inﬂammatory
diseases [17–19]. Our suggestion that TLR1 and TLR4
expression required MAPK activation is based on (i) our
previous observations that TPA induces a ROS-mediated
Erk1/2 activation in ML-1 cells [23, 27] and (ii) the TLR1
and TLR4 protein expression in ML-1 induced by TPA was
blocked by U0126, an agent that is known to eﬀectively
suppress MEK activity. This observation is consistent with
previous reports by Jang et al. [36] that demonstrated that
TPA-induced TLR2 expression in U937 cells was mediated
viaanErk1/2andROS-independentsignalmechanisms[36].
ROS generation in response to bacterial LPS and LTA
is crucial for pathogen killing by immune cells [8, 44].
However, sustained production of ROS during immune
responses and sepsis can cause damage to macromolecules,
cell death and tissue injury [45, 46]. In TPA-diﬀerentiated
ML-1 cells we have identiﬁed two sources of ROS, NAD(P)H
oxidase, and the mitochondrial electron transport chain
[27]. Here, we demonstrated that TPA-diﬀerentiated ML-1
cellsexhibitaprolongedgenerationofROSuponstimulation
with LPS and LTA. Our conclusion that the mitochondrial
electron transport chain and/or NADPH oxidase may be the
source(s) of this ROS is based on the observation that DPI
(10μM), an agent that we have shown eﬀective in inhibiting
both NADPH oxidase and mitochondria complex Iin ML-
1 cells [27], immediately and completely suppressed the
prolonged ROS generation induced by LPS and LTA. While
DPI inhibition does not allow us to conclude the source of
ROS elicited by LPS and LTA, there are several studies that
havedemonstratedinteractionsbetweenTLRandmitochon-
dria. For example, a recent study has shown that a subset
of toll-like receptors (TLR1, TLR2, and TLR4) promote
recruitment of mitochondria to macrophage phagosomes
and induce the generation of mitochondrial ROS. These
results implicate mROS as an important component of
antibacterial responses and establish mitochondria as hubs
for innate immune signaling [8]. Similarly, toll-like receptor
4 mediates ROS-mediated mitochondrial DNA damage and
biogenic responses in the liver of mice exposed to heat-
inactivatedE.coli[47].Collectively,thedatapresentedinthis
study demonstrate that TPA-induced diﬀerentiation of ML-
1 cells to macrophages is accompanied by the expression of
members of the TLR/IRAK-2/NF-κBc o m p l e x .T h i sl e a d st o
arobustdownstreamTLR/IRAK-2/NFκB-mediatedcytokine
production and an increase in sustained cellular oxidative
metabolismandROSuponcellularinteractionwithbacterial
LPS and LTA.
Abbreviations
TPA, LPS, LTA, ROS: 12-tetradecanoyl-phorbol-13-acetate.
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